References
1. Mendes C, Costa J, Vicente AA, Oliveira MBPP, Mafra I. Cashew Nut Allergy: Clinical Relevance and Allergen Characterisation. Clin Rev Allergy Immunol . 2019;57(1):1-22. doi:10.1007/s12016-016-8580-5
2. Johnson J, Malinovschi A, Alving K, Lidholm J, Borres MP, Nordvall L. Ten-year review reveals changing trends and severity of allergic reactions to nuts and other foods. Acta Paediatr Int J Paediatr . 2014;103(8). doi:10.1111/apa.12687
3. McWilliam V, Koplin J, Lodge C, Tang M, Dharmage S, Allen K. The Prevalence of Tree Nut Allergy: A Systematic Review. Curr Allergy Asthma Rep . 2015;15(54). doi:10.1007/s11882-015-0555-8
4. Crealey M, Alamin S, Tormey V, Moylett E. Clinical presentation of cashew nut allergy in a paediatric cohort attending an allergy clinic in the West of Ireland. Ir J Med Sci . 2019;188:219-222. doi:10.1007/s11845-018-1801-6
5. Clark AT, Anagnostou K, Ewan PW. Cashew nut causes more severe reactions than peanut: Case-matched comparison in 141 children.Allergy . 2007;62(8):913-916. doi:10.1111/j.1398-9995.2007.01447.x
6. Wang J, Sampson HA. Safety and efficacy of epicutaneous immunotherapy for food allergy. Pediatr Allergy Immunol . 2018;29(4):341-349. doi:10.1111/pai.12869
7. Mondoulet L, Dioszeghy V, Thébault C, Benhamou PH, Dupont C. Epicutaneous immunotherapy for food allergy as a novel pathway for oral tolerance induction. Immunotherapy . 2015;7(12). doi:10.2217/imt.15.86
8. Mondoulet L, Dioszeghy V, Puteaux E, et al. Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice. Clin Transl Allergy . 2012;2(22). doi:10.1186/2045-7022-2-22
9. Hervé P-L, Dhelft V, Plaquet C, et al. Epidermal micro-perforation potentiates the efficacy of epicutaneous vaccination. J Control Release . 2019;298:12-26. doi:10.1016/j.jconrel.2019.02.004
10. Mattison CP, Malveira Cavalcante J, Izabel Gallão M, Sousa de Brito E. Effects of industrial cashew nut processing on anacardic acid content and allergen recognition by IgE. Food Chem . 2018;240:370-376. doi:10.1016/j.foodchem.2017.07.146
11. Mattison CP, Bren-Mattison Y, Vant-Hull B, Vargas AM, Wasserman RL, Grimm CC. Heat-induced alterations in cashew allergen solubility and IgE binding. Toxicol Reports . 2016;3:244-251. doi:10.1016/j.toxrep.2015.12.009
12. Brough HA, Liu AH, Sicherer S, et al. Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy. J Allergy Clin Immunol . 2015;135(1). doi:10.1016/j.jaci.2014.10.007
13. Finkelman FD. Anaphylaxis: Lessons from mouse models. J Allergy Clin Immunol . 2007;120(3):506-515. doi:10.1016/j.jaci.2007.07.033
14. Dioszeghy V, Mondoulet L, Laoubi L, et al. Antigen uptake by Langerhans cells is required for the induction of regulatory T cells and the acquisition of tolerance during epicutaneous immunotherapy in OVA-sensitized mice. Front Immunol . 2018;9(1951). doi:10.3389/fimmu.2018.01951
15. Tordesillas L, Lozano-Ojalvo D, Dunkin D, et al. PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs. Nat Commun . 2018;9(1). doi:10.1038/s41467-018-07716-7
16. Pereira MA, Rebouças J de S, Ferraz-Carvalho R de S, et al. Poly(anhydride) nanoparticles containing cashew nut proteins can induce a strong Th1 and Treg immune response after oral administration.Eur J Pharm Biopharm . 2018;127:51-60. doi:10.1016/j.ejpb.2018.02.011
17. Sampson HA, Shreffler WG, Yang WH, et al. Effect of varying doses of epicutaneous immunotherapy vs placebo on reaction to peanut protein exposure among patients with peanut sensitivity: A randomized clinical trial. JAMA - J Am Med Assoc . 2017;318(18):1798-1809. doi:10.1001/jama.2017.16591
18. van de Veen W, Akdis M. Role of IgG4 in IgE-mediated allergic responses. J Allergy Clin Immunol . 2016;138(5):1434-1435. doi:10.1016/j.jaci.2016.07.022
19. Snapper CM, Paul WE. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science (80- ) . 1987;236(4804):944-947. doi:10.1126/science.3107127
20. Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol . 2004;113(3):395-400. doi:10.1016/j.jaci.2003.11.025
21. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med . 2012;18(5):693-704. doi:10.1038/nm.2755
22. Mayr SI, Zuberi RI, Liu FT. Role of immunoglobulin E and mast cells in murine models of asthma. Brazilian J Med Biol Res . 2003;36(7):821-827. doi:10.1590/S0100-879X2003000700001
23. van Halteren AGS, van der Cammen MJF, Biewenga J, Savelkoul HFJ, Kraal G. IgE and mast cell responses on intestinal allergen exposure: A murine model to study the onset of flood allergy. J Allergy Clin Immunol . 1997;99(1):94-99. doi:10.1016/S0091-6749(97)70305-1
24. Gladys Ang WX, Church AM, Kulis M, Choi HW, Wesley Burks A, Abraham SN. Mast cell desensitization inhibits calcium flux and aberrantly remodels actin. J Clin Invest . 2016;126(11):4103-4118. doi:10.1172/JCI87492
25. Oka T, Rios EJ, Tsai M, Kalesnikoff J, Galli SJ. Rapid desensitization induces internalization of antigen-specific IgE on mouse mast cells. J Allergy Clin Immunol . 2013;132(4):922-932. doi:10.1016/j.jaci.2013.05.004
26. Dioszeghy V, Mondoulet L, Puteaux E, et al. Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut. Cell Mol Immunol . 2017;14(9):770-782. doi:10.1038/cmi.2016.14
27. Tordesillas L, Mondoulet L, Blazquez AB, Benhamou PH, Sampson HA, Berin MC. Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis. J Allergy Clin Immunol . 2017;139(1):189-201. doi:10.1016/j.jaci.2016.03.057
28. Kim EH, Burks AW. Food allergy immunotherapy: OIT and EPIT.Allergy . Published online 2020. doi:https://doi.org/10.1111/all.14220
29. Bastiaan-Net S, Reitsma M, Cordewener JHG, et al. IgE Cross-Reactivity of Cashew Nut Allergens. Int Arch Allergy Immunol . 2019;178(1):19-32. doi:10.1159/000493100